Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-046507

Chief Commercial Officer acquired 561 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Marshak Richard Chief Commercial Officer 2026-06-30 Grant or award +561 $3.87 $2,171 128,319 D
Loading xslF345X06/wk-form4_1782936164.xml…